0000899243-21-008032.txt : 20210224 0000899243-21-008032.hdr.sgml : 20210224 20210224170035 ACCESSION NUMBER: 0000899243-21-008032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210223 FILED AS OF DATE: 20210224 DATE AS OF CHANGE: 20210224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Andrew Craig CENTRAL INDEX KEY: 0001777760 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 21674527 MAIL ADDRESS: STREET 1: C/O KARUNA THERAPEUTICS, INC. STREET 2: 33 ARCH STREET, SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 ARCH STREET STREET 2: SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 33 ARCH STREET STREET 2: SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-23 0 0001771917 Karuna Therapeutics, Inc. KRTX 0001777760 Miller Andrew Craig C/O KARUNA THERAPEUTICS, INC., 33 ARCH ST STE 3110 BOSTON MA 02110 0 1 0 0 Chief Operating Officer Option (right to buy) 131.64 2021-02-23 4 A 0 66900 0.00 A 2031-02-22 Common Stock 66900 66900 D 25% of this option shall vest on February 23, 2022, and the remaining options shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates /s/ Troy Ignelzi, Attorney-in-Fact 2021-02-24